FREMONT, Calif.--(BUSINESS WIRE)--Shockwave Medical, a pioneer in the treatment of peripheral and coronary vascular disease, today announced that the company will present clinical results from DISRUPT PAD, a single-arm multicenter study evaluating the safety and utility of Lithoplasty™ balloon catheters for the treatment of peripheral artery disease, at the Vascular Interventional Advances (VIVA) Annual Conference taking place November 4-7 in Las Vegas, Nevada.
Help employers find you! Check out all the jobs and post your resume.
